TMCnet News
Research and Markets: Global Cardiac POC Market Report 2014-2018: Alere Inc, Abbott Laboratories & Roche Diagnostics Dominates the IndustryDUBLIN --(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/l2lvgs/global_cardiac) has announced the addition of the "Global Cardiac POC Market 2014-2018" report to their offering. This report covers the present scenario and growth prospects of the Global Cardiac POC market for the period 2014-2018. To calculate the market size, the report considers revenue generated from the sales of two type of tests: Troponin and brain natriuretic peptide tests, which are used to treat Cardiac POC. Furthermore, the report considers revenue generated from the following type of tests - Biosite Triage, Cobas and i-STAT. Vendors in the market are focusing on the introduction of new enhanced products to meet the needs of customers, providing better services in the diagnosis. The Healthcare ndustry takes a significant amount of time from the designing to its product launch. In addition, emerging technology in the Medical Diagnostics industry leads to an increase in competition among vendors, resulting in the development of new products in the market. According to the report the Global Cardiac POC Testing Devices market is growing at a steady rate and is expected to post a CAGR of 14.4 percent during the forecast period. Advances in diagnostic technologies and an increase in the incidence of CVDs are expected to contribute to the growth of the market. In 2013, the Americas dominated the market, followed by the EMEA and APAC regions. The US, which has the world's highest per capita healthcare expenditure, was the leading country in 2013. Further, the report states the Global Cardiac POC Testing Devices market is driven by several factors, one of which is the increase in the incidence of cardiac disorders. The increasing incidence of CVDs, HF, and coronary syndromes is leading to an increase in acceptance of cardiac POC tests as they provide rapid diagnostics for analyzing the specificity of the disease. The report also includes a discussion of the other vendors operating in this market. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. Key Vendors
Other Prominent Vendors
For more information visit http://www.researchandmarkets.com/research/l2lvgs/global_cardiac
|
